AbstractHIVInternational Workshop on HIV & Women 2021Double Dose Levonorgestrel Emergency Contraception Overcomes Drug to Drug Interactions with EfavirenzView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021Rilpivirine Long-Acting Pharmacokinetic Tail and PregnancyView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021Progression of Symptoms During the Menopause Transition in Women Living With HIVView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021Comorbidity Risk Scores and Immune Aging Markers in Women Over 45 Years Old Living with Or Without HIV In the Carma Cohort in British Columbia: A Preliminary AnalysisView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021Hot Flashes and Cardiovascular Disease Risk Indices Among Women With HIVView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021Breastfeeding and HIV In the U.S. And Canada: Centering Women’s Lived Experiences into The Clinical, Research, And Policy DiscussionView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021The Mental Health of Women Aged 45-60 Living with HIV In England: A Latent Class Analysis of The PRIME StudyView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021Angiopoietin 2 Levels Are Elevated in the 3rd Trimester in The Plasma of Pregnant Women Living with HIV on PI-Based ART: A Potential Biomarker Of PI-Associated Increased Placental AngiogenesisView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021Patterns of Changing Pregnancy Intentions Among Women Living with HIV In CanadaView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021HPV-Related Cancer Awareness Among Women and Trans And Gender Diverse People Living with HIV – A Community SurveyView Abstract
AbstractHIVInternational Workshop on HIV & Women 2021Meta-Analysis of RCTs To Assess Weight Gain and Sex Differences with INSTI Or TAF Regimens in ARV Treatment Naïve Persons Living With HIV-1 InfectionView Abstract